[Hinews] SEOUL, South Korea — August 18, 2025 — ROKIT Healthcare, a South Korean biotechnology firm specializing in regenerative medicine, announced Monday that it has entered into a supply agreement with Alliant Purchasing, a prominent U.S. group purchasing organization (GPO) representing over 35,000 healthcare facilities nationwide.

Facilitated by ROKIT’s U.S. partner, Tides Medical, the agreement enables Alliant’s member hospitals and clinics to access ROKIT’s advanced regenerative medicine products. Alliant collaborates with healthcare systems to secure bulk purchasing contracts, balancing cost efficiency with high-quality care standards.

ROKIT Healthcare logo (Provided by ROKIT Healthcare)
ROKIT Healthcare logo (Provided by ROKIT Healthcare)


The deal marks a strategic move by ROKIT to deepen its presence in the U.S. healthcare market, where GPOs like Alliant play a pivotal role in shaping hospital procurement and driving the adoption of innovative medical technologies.
“This partnership not only opens doors to healthcare providers but also creates opportunities across diverse industries,” a ROKIT Healthcare spokesperson said. “It’s a vital step toward expanding our global supply chain and strengthening our market position.”

Financial details of the agreement were not disclosed.

키워드

#로킷헬스케어#알리안트
저작권자 © Hinews 무단전재 및 재배포 금지
ad